Increased HCP engagement veeva.com/eu According to the 2017 World Drug Report, 29.5 million people suffer from drug use disorders. For more than two decades, Indivior has innovated medicines for the treatment of opioid use disorder and employs a wide range of activities to educate and engage healthcare professionals (HCPs) about the disease. In preparation to launch a new product, Indivior recognized the need to scale its global commercial infrastructure quickly to better enable brand and field teams to educate HCPs upon approval. INDIVIOR – AT A GLANCE • Global HQ: Richmond, VA • Established in 1994 by Reckitt Benckiser Group plc; incorporated as Indivior PLC in 2014 • 1,000+ employees worldwide • Focus: Expanding access to evidence-based treatments and developing innova

Join for free to read